You are here

Tryp Therapeutics Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
TRYP
CSE Index: 
Currency: 

The Company is a pharmaceutical company focused on bringing transformative medicine with known safety profiles to diseases with no effective first-line treatments. The Company intends to do this through the development of compounds with known activity and/or safety profiles. The Company’s lead program is designed to address neurological disorders through the therapeutic dosing of synthetic psilocybin. The Company is currently evaluating potential lead indications for its psilocybin-for-neurology program, which it refers to as its PFN™ program, including fibromyalgia and Prader-Willi Syndrome. In addition to its PFN™ program, the Company is developing razoxane for the treatment of soft-tissue sarcomas. The Company continues to evaluate potential additional indications for its existing programs, as well as other drug candidates with known activity and/or safety profiles that may have utility in the treatment of rare diseases or other diseases with high unmet medical needs.

You are here

Tryp Therapeutics Inc. (TRYP)

SEDAR Information

Company Info

Address
335-1632 Dickson Avenue
Kelowna, BC V1Y7T2
Canada
Phone
250-717-1840
Fax
250-717-1845
Website
http://www.tryptherapeutics.com
Listing date
Wednesday, December 16, 2020
Transfer Agent
Capital Transfer Agency

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
66,320,171
Reserved for Issuance: 
20,433,743

Bulletins

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-04-15-The-Future-of-Food-2.0-Investor-Conference_Website_1.jpg

The Future of Food 2.0 Investor Conference

Thursday, April 15, 2021 -
11:00am to 2:30pm